Our work related to family, domestic and sexual violence

This program provides funding to strategically important aged care providers facing financial viability concerns. From 1 November 2025, MAP will expand to include both residential and Support at Home providers to ensure continuity of care for care recipients. Applications are by invitation only.

Maternal Health and First 2000 Days/Women’s Health has been consolidated into the Preventive and Public Health Research initiative under the MRFF 10-year Investment Plan.

This program helps Aboriginal and Torres Strait Islander people who have chronic conditions to access health care. It does this by covering some costs – like travel and accommodation – for health professionals who provide the outreach services.

The Medical Research Commercialisation initiative will provide $450 million over 10 years from 2024–25 to support innovative early stage health and medical research in Australia. It will help researchers transform ideas into life-saving medicines, devices and treatments to help future patients.

The Medical Research Future Fund (MRFF) is a $24.5 billion long-term investment supporting Australian health and medical research. The MRFF aims to transform health and medical research and innovation to improve lives, build the economy and contribute to health system sustainability.

The Medical Rural Bonded Scholarship Scheme has closed to new applicants. Existing participants can either continue with this scheme or opt in to the more flexible Bonded Medical Program.

The Medical Treatment Overseas Program (MTOP) helps approved Australians who have a life-threatening medical condition access life-saving medical treatment overseas where treatment is not available in Australia.

The MBS Continuous Review ensures the MBS continues to support high-quality care, remains flexible, and stays up to date. We do this through a process of ongoing expert reviews.

The MBS Review considered how MBS items could be better aligned with contemporary clinical evidence and practice, to improve health outcomes. The review ran from 2015 to 2020. The Australian Government has progressively considered and implemented the recommendations.